Schwabe. Characterization of adenosine A 1 receptor in a cell line (28A) derived from rabbit collecting tubule. Am. J. Physiol. 263 (Cell Physiol. :32): C502-C508, 1992.-We have previously reported that in several renal cell types, adenosine receptor agonists inhibit adenylyl cyclase and activate phospholipase C via a pertussis toxin-sensitive G protein. In the present study, in 28A cells, both uf these adenosine receptor-mediated responses were inhibited by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). a highly selective A 1 adenosine receptor antagonist. The binding characteristics of the adenosine A 1 receptor in the 28A renal cell line were studied using the radiolabeled antagonist f:
1 H]DPCPX to determine whether two separate binding sites could account for these responses. Saturation binding of [: 1 H]DPCPX to 28A cell membranes revealed a single class of A 1 binding sites with an apparent Kd value of 1.4 nM and maximal binding capacity of 64 fmol/mg protein. Competition experiments with a variety of adenosine agonists gave biphasic displacement curves with a pharmacological profile characteristic of A 1 receptors. Comparison of [: 1 H]DPCPX competition binding data from 28A cell membranes with rabbit brain membranes, a tissue with well-characterized A 1 receptors, reveals that the A 1 receptor population in 28A cells has similar agonist binding affinities to the receptor population in brain but has a considerably lower density. Addition of guanosine ;) ' -triphosphate ( 100 ,uM) to 28A cell membranes caused the competition curves to shift from biphasic to monophasic. indicating that the A 1 receptors exist in twu interconvertible affinity states because of their coupling to G proteins. In the absence of evidence for subpopulations of the A 1 receptor, it appears that in 28A cells. a single A 1 receptor population. as defined by Iigand binding characteristics, couples via one or more pertussis toxin-sensitive guanine nucleotide binding proteins to two different biological signaling mechanisms. calcium: phosphoinositides: adenosine :r .. 1' -cyclic monophosphate; receptor binding; signal transduction; G proteins ADENOSINE is a ubiquitous compound that, among other actions, alters hemodynamics. inhibits neurotransmission, platelet aggregation, and lipolysis. and stimulates glucose oxidation ( 1, 14, 16) . Previous research has demonstrated the existence of two extracellular receptors for adenosine through which changes in adenylyl cyclase activity and adenosine :3' .5' -cyclic monophosphate (cAMP) production are mediated (11, 13, 24, 25) . These receptors are denoted A 1 and A~. and their binding to agonist results in the inhibition and Stimulation of cAMP production, respectively. Recent cloning of these two receptors ( 21, 26) shows them to be members of the large class of hormone receptors that, like the visual pigment rhodopsin, are coupled to their intracellular effector systemsvia guanine nucleotide binding proteins (G proteins) .
Radiolabeled binding studies have revealed the presence of both of these receptor types in the renal cortex and medulla in a variety of species (6, 10, 28. 30, 34) , although in most of these studies no distinction can be made as to the particular renal cell types or nephron segments that might possess the receptors, and the postreceptor signaling mechanism cannot be ascertained. Recent reports from this laboratory have demonstrated the presence of A 1 -and A~-like effects of adenosine analogues on cAMP accumulation in primary cultures of rabbit cortical collecting tubule (RCCT) cells ( 4) and rabbit thick ascending limb of the loop of Henle (mTAL) cells (9).
We recently demonstrated in primary cultures of RCCT cells (2) and in RCCT -28A cells (28A cells), a cloned cell line derived from RCCT cells (3), that in addition to the classical A 1 and A:2 receptors coupled to the inhibition and stimulation of adenylyl cyclase, respectively, adenosine receptor agonists also stimulate the turn<wer of membrane inositol phosphates and cause the elevation of cytosolic free calcium. Similar to the inhibition of cAMP, these responses are coupled to a pertussis toxin-sensitive G protein and are inhibited by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a xanthine derivative that blocks the A 1 -mediated inhibition of cAMP hut has no effect on the 5' -(N-ethylcarboxamido)adenosine (NECA)-induced (A 2 ) increase in cAMP (2). Theseobservations suggest that the adenosine-induced acceleration of inositol phosphate production and elevation of cytosolic free calcium concentration ([Ca:2+JJ may result from activation of A 1 adenosine receptors.
The presence of two different signaling mechanisms associated with adenosine A 1 receptor activation raises the question of whether two classes of A 1 receptors exist. One possibility is that both the inhibition of adenylyl cyclase and the increase in inositol phosphate production are evoked by activation of a single receptor populationvia divergent coupling mechanisms. i\lterna-tively, the two responses may be the result of independent A 1 receptor subpopulations indistinguishable in their specificity for currently available agonist or antagonist ligands.
Although binding analysis of A 1 adenosine receptors has been reported in a variety of tissues and cells, it has not been reported for a cell type that exhibits multiple signaling mechanisms associated with activation of the A 1 receptor. The present study provides a detailed characterization of the adenosine A 1 receptor through the use of radiolabeled Iigand binding analysis and concentration-effect inhibition studies using DPCPX, a relatively specific A 1 antagonist. and pertussis toxin in an attempt to determine whether a single population of A 1 recepturs is coupled tu divergent signaling pathways. (2, 18) using the f1uorescent Ca 2 + chelator, fura-2. The 28A cells were detached from culture dishes by brief trypsin treatment, and the cell suspensions ( -10 7 cells/ ml) were treated with fura-2/ AM (final concn 8 ,uM) in simplified saline solution (SSS) containing 2 U adenosine deaminase (ADA)/ml SSS for 30 min at :noc in a shaking water bath.
The cells were centrifuged and washed with SSS f composition in mM: 145 NaCl, 5 KCl, 1 Na 2 HP0 4 , 1 CaCl 2 • 0.5 MgCl 2 • 5 glucose. and 10 N-2-hydroxyethylpiperazine-N' -2-ethane-sulfonic acid (HEPES), pH 7.4]. The cells were diluted 1:100 with SSS. and fluorescence was measured with a SPEX dual-wavelength spectrofluorimeter, with :340-and ~380-nm excitation wavelengths and 505-nm emission wavelength.
Mea.
•wrement of total cyclic nucleotide accumulation. Treatments were clone in triplicate using cells grown for 4 days in 24-well dishes. Culture medium was removed, and the cells were washed once with Krebs buffer (in mM: 118 NaCl. 2f> NaHC0: 1 • 14 glucose, 4.7 KCl, 2 . .5 CaCl 21 1.8 MgS0 1 , and 1.8 KH 2 PO-t, pH 7 .4). The cells were pretreated for 1 h in Krebs solution containing 0.1 ml\11 4-(:1-butoxy-4-methoxybenzyl}-2-imidazolidinone (Ro 20-1724), a phosphodiesterase inhibitor that is not an adenosine receptor antagonist. and 2 C of ADA/ml Krebs at ;nac. After pretreatment. the buffer was aspirated and the cells were treated with Krebs plus Ru 20-1724 and ADA and containing the various hormones at :noc for :30 min. Treatment was terminated by adding 75 ,ul of 0.2 N HCI. The cells were frozen, thawed, allowed to stand at 4 oc for 60 min, and neutralized with 200 /oll of 0.5 mM Na:zHP0 4 • Total accumulated cAMP in the samples was determined by radioimmunoassay as described by Frandsen and Krishna ( 17) .
Preparation of membranes. Rabbit brain and renal medullary mernbranes were prepared as described earlier (2:~). Membranes from the 28A cells were prepared as described for rat glioma CB cells (:35 ) . Confluent 100-mm culture dishes of 28A cells of passages 7-10 were washed twice with cold phosphate-buffered saline (in mM: 1:38 NaCl, 1.5 KH 2 PO 1 • ;) KCl, and 8.1 ~a 2 HPO 1 • pH 7.4). The cells were washed once more with cold lysing buffer (5 mM HEPES and 1 mM MgS0 1 , pH 8.0) and kept in lysing buffer for 10 min at 4 "C. The cells were scraped from the plates and vortexed before being centrifuged at 1 ,.SOO {-{ for ;) min. The cells were washed once more with lysing buffer, and t he pellet was resuspended in 2 mM tris(hydroxymethyllaminomethane (Tris) · HCl (pH 7.4), 1 mM EDTA. and 0.2 ruM dithiothreitol before being disrupted with a Brinkmann Pol_v-tron (setting 6, 5-10 s). The cells were centrifuged at 600 g for 12 min. and the supernatant was collected and centrifuged at :36,000 g for :~0 min. The memhranes were resuspended in Tris · HCI (pH 7.4) and stored at -200C until use. Membrane protein was determined as described previously (:27) . H]CCPA) was synthesized and provided by Dr. Gloria Cristalli as described by Klotz et al. (unpublished observations) . Guanosine 5' -triphosphate (GTP) and ADA (200 U/mg) were obtained from Boehringer Mannheim. Trypsin ( 1::250) , DMEM. and fetal bovine serum were purchased from G IBCO Laboratories, Grand Island, NY. Fura-2/ AM was purchased from Molecular Probes. ,Junction City. OR. lsoproterenol was purchased from Sigma. DPCPX was purchased from Research Biochemicals. Wayland. MA. Pertussis toxin was purchased from List Biological Industries, CampbelL CA. The phosphodiesterase inhibitor, Ro 20- 17:24 . was purchased from BIOMOL Research Lahoratories. Plymouth Meeting, PA.
12 c'l-labeled adenosine :3' ,5' -cyclic monophosphoric acid was from ICN Biomedicals, Irvine, CA. Goat anti-cAMP antiserum was from Research Products, Mt. Prospect. IL. Other chemieals of reagent gmde or better were obtained from standard sources.
RESULTS

DPCPX functional studies. As demonstrated previously
in RCCT cells and the 28A cell line (:3. 4) . adenosine analogues inhibit hormone-stimulated cAMP accumulation. Figure 1A shows inhibition of isoproterenol-stimulated cAMP by Nn-cyclohexyladenosine (CHA) and the effect of the A 1 antagonist. DPCPX, on this inhibition. DPCPX (100 nM) completely blocks the inhibitory effect of CHA except at 1 .uM CHA. The effect of DPCPX on the adenosine analogue-induced increase in [Ca:2+L is shown in Fig. 1B . CHA increases [Ca:2+-L with an ""'50% effective concentration of 1 .uM. as previously described for RCCT cells (2, :1) , and 1 ,uM DPCPX completely inhibits this effect.
Pertussis toxin functional studies. In an attempt to characterize the G protein ( s) involved in the inhibition of cAMP and the increase in [Ca:.>+ L. detailed concentration-effect experiments were performed with varying concentrations of pertussis toxin. It could be expected that if different G proteins were associated with a single A 1 receptor type, the concentration of pertussis toxin required to produce ,)()'"'(; inhibition 11 ) would be different for each response. 28A cells were incubated for 18 h with concentrations of pertussis toxin ranging from 0.1 to 10 ng/ml (Table 1 ) . After this treatment with pertussis toxin. the cells were used either for studying the ability of CHA to inhihit 1 ,u l\1 isoproterenol-stimulated cA~IP or to stimulate an increase in cytosolic Ca:.> t- (Table 1 ).
In the absence of pertussis toxin. 1.0 ,uM CHA reduced the isoproterenol-stimulated increase in cAMP to 19% of that demonstrated with isoproterenol alone ( 100('~ stimulation). Treatment vvith 0.1 ng pertussis toxin/ml media did not affect the inhibition of cAMP, whereas increasing the pertussis toxin concentration to 1 ng/ml resulted in a marked reduction of the 0.1 and LO .uM CHA inhibition, to 60% of isoproterenol stimulation without CHA. Treatment with 10 ng pertussis toxin/ml resulted in further interference with the ability of 0.1 and 1.0 ~M CHA to inhibit cAMP, resulting in only 30% inhibition, and completely blocked the inhibition of cAMP produced by 0.01 p.M and 1.0 nM CHA. Pertussis toxin treatment did not significantly alter the ability of isoproterenol alone to increase cAMP (270 ± 34 to 1,680 ± 241 vs. 295 ± 49 to 2,156 ± 406 pmol cAMP /mg protein for no pertussis toxin and 10 ng pertussis toxin, respectively). Table 1 demonstrates the effect of varying concentrations of pertussis toxin on the CHA-induced increase in [Ca 2 +L. As with the inhibition of cAMP, treatment with pertussis toxin at 0.1 ng/ml had no effect on the ability of CHA to increase Ca 2 +. Pertussis toxin treatment at 1.0 ng/ml significantly reduced the increase in Ca 2 + produced by 0.1-10 ~M CHA, while 10 ng pertussis toxin/ml completely inhibited the increase in Ca 2 + in response to 0.01 and 0.1 ~M CHA and significantly reduced the increase by 1.0 and 10 p.M CHA. 28A cell membranes. Saturation binding of [:~H] DPCPX in 28A membranes (Fig. 3) , analyzed by nonlinear curve fitting, gave a one-site model with an apparent sites. The nonspecific binding was 20-30% of the total at the Kd, and saturation of specific binding was reached with 2 nM [:~H (Fig. 4) , indicating the presence of two affinity states for the agonists, with approximately half of the binding sites being in the high -affinity state and the other half in the low-affinity state. The Ki values for the various adenosine receptor agonists exhibit the typical pharmacological profile for A 1 receptors and the marked stereoselectivity for the PIA enantiomers. Agonist binding was further characterized by measuring the competition of R-PIA for r~H]DPCPX binding in the presence and absence of GTP (100 ,uM). In the absence of GTP, the competition of r~H]DPCPX by R-PIA resulted in a biphasic displacement curve with an apparent Kd value of 0.5 nM and Bmax value of 16.1 pmol/mg protein for the high-affinity state and a low-affinity Kd value of 10.5 nM and Bmax value of 20.2 fmol/mg protein (Fig. 5) .
When the competition experiment was carried out in the presence of 100 ,uM GTP (Fig. 5) [: 3 H]DPCPX binding by adenosine agonists yielded biphasic displacement curves that were similar in binding parameters to those described for the 28A cell membranes (Fig. 6) . H]DPCPX in absence of R-PIA. Control binding ( 100%) amounted to ;~6.~ and 54.1 fmol/mg prntein in absence and presence of GTP. respectively. In absence of GTP. curve was best fitted according to a 2-sit.e model. and K, values of 0.5 (highaffinity state) and 10.5 nM ilow-affinity state) were calculated. In presence of GTP. only 1 affinity state with a K, value of 17.7 nM was detected. agonists in rabbit brain membranes (Fig. 7) . Competition for rlH]DPCPX binding by adenosine agonist ligands yielded biphasic displacement curves with similar Kd values to those observed in the binding studies of 28A cell and renal medullary membranes.
DISCUSSION
The demonstration of two signaling mechanisms (i.e., inhibition of adenylyl cyclase and stimulation of phospholipase C) associated with the activation of adenosine A 1 receptors in the cortical collecting tubule cell and the RCCT -28A cell line and the finding that both responses can be blocked by pertussis toxin treatment (2, 3, 4) and by the A 1 receptor antagonist DPCPX raise the question of whether two subtypes of A 1 receptors exist. Several receptor types have been shown to couple to different signaling pathways, whereas other receptor populations contain many subtypes. each of which is monogamous in its coupling to signaling pathways.
Initially, studies of the a-adrenergic receptor demonstrated two receptor types: nradrenergic receptors specifically coupled to the inhibition of adenylyl cyclase and a 1 -adrenergic receptors coupled to the acceleration of phosphatidylinositol turnover; however, recently these receptors have been shown to consist of several subtypes, with each possibly interacting with more than one signaling pathway. It is becoming increasingly clear that a variety of cell surface receptors are coupled to more than one intracellular signaling mechanism. Angiotensin (7), prostagtandinE (29), and P~ purinergic (31) receptors are examples of receptor types that appear to couple to both adenylyl cyclase and phosphoinositide metabolism without any conclusive evidence of different subclasses of receptors. The muscarinic cholinergic receptor also mediates several different biological responses (a decrease in cAMP by 2 independent mechanisms and increases in phosphoinositide hydrolysis. cyclic G l\t1P accumulation, and K+ permeability), but attempts to associate these with different receptor subt_ypes yielded equivocal results in several earlier studies (8, 15, 19. 33) . There is also recent evidence that some muscarinic receptor subt_ypes couple to phosphoinositide turnover without affecting adenylyl cyclase (:.32) . Thus a precedent exists for both models: separate but similar populations of receptors coupled to separate signaling mechanisms or one receptor population Controlling divergent effector systems. The aim of the present study was to characterize the A 1 adenosine receptor population in RCCT -28A cells and in doing so attempt to determine the existence of two adenosine A 1 receptor subtypes.
DPCPX and pertussis toxin are both known to interfere with the ability of adenosine analogues to inhibit cAl\tfP and to stimulate phosphoinositide turnover and subsequently increase Ca:!+. D PCPX is a highly specific A 1 adenosine receptor antagonist, while pertussis toxin ADP-ribosylates and inactivates the Gi protein associated with the A 1 receptor. DPCPX and pertussis toxin were used at several concentrations in the present study in an attempt to uncover a difference in IC_-, 11 of these agentstoblock the CHA-induced inhibition of cAlVIP vs. the stimulation of phosphoinositide turnover and increase in Ca~+. A difference in the potency of DPCPX or pertussis toxin to inhibit these two phenomena would have provided evidence for different receptors or different Gi proteins, respectively. However, the potencies for DPCPX and pertussis toxin to inhibit the cAl\tiP response compared with the respective IC.-,11 values for the Ca~+ response were not appreciably different, therefore failing to provide support for the hypothesis that there are two different receptors or even two different G proteins associated with the same receptor. These results do not, however. preclude the possibility of receptors that are similar in their sensitivity to DPCPX (Fig. 4) gave biphasic competition curves, with Ki values similar to those obtained in rabbit brain membranes in the present study (Fig. 7) andin previous studies (22) . In the presence ofGTP. the competition curve of [:'H] DPCPX binding with increasing concentrations of R-PIA was shifted from biphasic to monophasic (Fig. 3) . This finding indicates that the A 1 receptor in the 28A cell membranes exists in both highand low-affinity states foragonist binding in the absence of GTP and that addition of GTP converted all A 1 receptors into the low-affinity state. The rank order of potency for adenosine agonists and the effects of GTP on agonist binding observed in the present studies are entirely in keeping with what is known about the binding properties of the A 1 receptor in other tissues.
Comparison of the A 1 Iigand binding characteristics of the 28A cell line membranes with membranes from the rabbit renal medulla and rabbit brain. a tissue in which adenosine A 1 receptors are well characterized, indicates that although the cellline and renal medulla have much lower receptor density than brain, adenosine agonists have similar affinity for A 1 receptors of renal origin as for brain A, receptors. Furthermore. the similar binding characteristics between the 28A cell line and the renal medulla and our previous report on the mobilization of [Ca 2 +L (2) and stimulation of inositol phosphate metabolism (3) indicate that the 28A cellline is a useful model in which to investigate the adenosine A, receptor and its signaling mechanisms.
The binding data in this study fail to provide support for the hypothesis that the inhibition of adenylyl cyclase and the stimulation of phospholipase C are coupled to two subpopulations of the A 1 receptor. although it is recognized that this conclusion may be a function of the inability of currently available ligands to differentiate between the A 1 receptor suht:v'J)es. \Ve also recogn ize the possibility that a suhpopulation of the A 1 receptor. if ver:.· small compared with the maximum mimher of binding sites for [: 1 H] D PCPX ( i.e., < 10% ), might escape detection by saturation analysis. However. given the relatively low abundance of A 1 receptors presently found in these tissues (;30-70 fmol/mg protein), it seems unlikely that a subpopulation with a receptor density of <10 pmol/mg protein could be responsible for the functional changes in Ca 2 + mobilization and inositol phosphate formation that we have previously observed ( 2, :1). Failure to observe more than a single class of A 1 receptors by antagonist radioligand binding leads us to suggest that in the collecting tubule celL adenosine mediates both the inhibition of adenylyl cyclase and activation of phospholipase C via a single population of A 1 receptors. An unequivocal test of the hypothesis that one receptor population mediates both responses would be the insertion of the cloned A 1 adenosine receptor into cells lacking this receptor and the demonstration that adenosine elicits both biological responses in these rells.
